skip to Main Content

2022 AIM-HI Women’s Venture Competition Announced 6 Semi-Finalists!

The AIM-HI Accelerator Fund (AIM-HI) just announced 6 Semi-Finalists for the 2022 AIM-HI Women’s Venture Competition! These innovative oncology start-ups have been selected from an exceptional pool of applications submitted by women scientist-entrepreneurs worldwide. The AIM-HI Women’s Venture Competition, now…

Leading Game-changing Discoveries | Sujuan Ba, Ph.D.

We're excited that Dr. Sujuan Ba, AIM-HI CEO & Co-Founder, is featured as one of the "20 Most Inspiring Women Leaders 2022" by THE WOMEN LEADERS Magazine. Read about her illustrious career leading three successful non-profits in the field of cancer…

Applications Open for the 2022 AIM-HI Women’s Venture Competition!

We have great news to share! The 2022 AIM-HI Women’s Venture Competition is Now Open for Applications! This unique funding program, now in its third year, provides investment, coaching, and networking opportunities to women-led oncology startups. Companies with a woman…

Celebrating Progress in Cancer Research and Entrepreneurship!

The AIM-HI Accelerator Fund is fiercely dedicated to accelerating the commercialization of innovative lab breakthroughs into life-saving new therapies and technologies. These words evoke a pathway. A pathway of progress that connects cancer research lab breakthroughs to game-changing novel technologies.…

2021 Women’s Venture Competition Announced Semi-Finalists!

The AIM-HI Accelerator Fund just announced 10 semi-finalists for the 2021 Women’s Venture Competition! These oncology companies have been selected from among an exceptional pool of applications submitted globally by women scientist-entrepreneurs. Decision making was led by a selection committee…

Making Cancer Patient Clinical Trial Recruitment & Engagement Easier

Are you struggling to increase clinical trial awareness, recruitment, and participant retention for your oncology drug trials? Building up an efficient pre-screening process becomes an urgent task for companies to connect with potential participants; keep them engaged through the trial…

Back To Top